Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gastrointestinal behavior of atazanavir in healthy volunteers
2017-004579-29Phase 4Completed
- Sponsor
- KU Leuven
- Start
- Jan 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of atazanavir (2 arms), sponsored by KU Leuven. Primary endpoint: Gastrointestinal behavior and supersaturation of atazanavir. Started Jan 2018; status: completed.
02
Drugs
atazanavir
Beyond the preview
Go deeper on 2017-004579-29.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-004579-29.